Bio-Orthogonal Chemistry Conjugation Strategy Facilitates Investigation of N-methyladenosine and Thiouridine Guide RNA Modifications on CRISPR Activity.

The CRISPR-Cas9 system is an important genome editing tool that holds enormous potential toward the treatment of human genetic diseases. Clinical success of CRISPR technology is dependent on the incorporation of modifications into the single-guide RNA (sgRNA). However, chemical synthesis of modified sgRNAs, which are over 100 nucleotides in length, is difficult and low-yielding. We developed a conjugation strategy that utilized bio-orthogonal chemistry to efficiently assemble functional sgRNAs containing nucleobase modifications. The described approach entails the chemical synthesis of two shorter RNA oligonucleotides: a 31-mer containing tetrazine (Tz) group and a 70-mer modified with a trans-cyclooctene (TCO) moiety. The two oligonucleotides were conjugated to form functional sgRNAs. The two-component conjugation methodology was utilized to synthesize a library of sgRNAs containing nucleobase modifications such as N1-methyladenosine (m1A), N6-methyladenosine (m6A), 2-thiouridine (s2U), and 4-thiouridine (s4U). The impact of these RNA modifications on overall CRISPR activity were investigated in vitro and in Cas9-expressing HEK293T cells.

[1]  P. Zamore,et al.  Tetrazine-Ligated CRISPR sgRNAs for Efficient Genome Editing , 2022, ACS chemical biology.

[2]  S. Pääbo,et al.  Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage , 2022, Nature communications.

[3]  C. Destache,et al.  1084. Comparative Outcomes Among Patients Receiving Varying Daptomycin Dosing Regimens in Hemodialysis , 2021, Open Forum Infectious Diseases.

[4]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.

[5]  Amanda M Li,et al.  CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. , 2020, The New England journal of medicine.

[6]  J. Mascola,et al.  An mRNA Vaccine against SARS-CoV-2 — Preliminary Report , 2020, The New England journal of medicine.

[7]  S. Lacey,et al.  First Trial of CRISPR-Edited T cells in Lung Cancer. , 2020, Trends in molecular medicine.

[8]  H. Bonkovsky,et al.  Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria. , 2020, The New England journal of medicine.

[9]  X. Yi,et al.  Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer , 2020, Nature Medicine.

[10]  P. J. McCown,et al.  Naturally occurring modified ribonucleosides , 2020, Wiley interdisciplinary reviews. RNA.

[11]  R. Batey,et al.  Small molecule regulated sgRNAs enable control of genome editing in E. coli by Cas9 , 2020, Nature Communications.

[12]  Heidi Ledford,et al.  CRISPR treatment inserted directly into the body for first time , 2020, Nature.

[13]  Howard Y. Chang,et al.  CRISPR-engineered T cells in patients with refractory cancer , 2020, Science.

[14]  Leslie S. Edwards,et al.  Harnessing type I CRISPR–Cas systems for genome engineering in human cells , 2019, Nature Biotechnology.

[15]  Chuan He,et al.  Evolution of a Reverse Transcriptase to Map N1-Methyladenosine in Human mRNA , 2019, Nature Methods.

[16]  T. Brown,et al.  An artificial triazole backbone linkage provides a split-and-click strategy to bioactive chemically modified CRISPR sgRNA , 2019, Nature Communications.

[17]  Haiyan Jiang,et al.  Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10 , 2019, Nature Medicine.

[18]  M. Damha,et al.  Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity , 2018, Nucleic acids research.

[19]  S. Solomon,et al.  Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis , 2018, The New England journal of medicine.

[20]  A. Khvorova,et al.  Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editing , 2018, Nature Communications.

[21]  W. Harrington,et al.  A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing. , 2018, Cell reports.

[22]  Robert Langer,et al.  Partial DNA-guided Cas9 enables genome editing with reduced off-target activity. , 2018, Nature chemical biology.

[23]  Israel Steinfeld,et al.  Improving CRISPR–Cas specificity with chemical modifications in single-guide RNAs , 2017, Nucleic acids research.

[24]  D. Rueda,et al.  Mapping the sugar dependency for rational generation of a DNA-RNA hybrid-guided Cas9 endonuclease , 2017, Nature Communications.

[25]  Daniel G. Anderson,et al.  Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing , 2017, Nature Biotechnology.

[26]  Schraga Schwartz,et al.  The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution , 2017, Nature.

[27]  Rick L. Stevens,et al.  A communal catalogue reveals Earth’s multiscale microbial diversity , 2017, Nature.

[28]  Chuan He,et al.  N6-methyladenosine (m6A) recruits and repels proteins to regulate mRNA homeostasis , 2017, Nature Structural &Molecular Biology.

[29]  Jennifer A. Doudna,et al.  Enhanced proofreading governs CRISPR-Cas9 targeting accuracy , 2017, Nature.

[30]  J. Doudna,et al.  CRISPR-Cas9 Structures and Mechanisms. , 2017, Annual review of biophysics.

[31]  Ligang Wu,et al.  YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex , 2016, Nature Communications.

[32]  M. Royzen,et al.  In Vivo Bioorthogonal Chemistry Enables Local Hydrogel and Systemic Pro-Drug To Treat Soft Tissue Sarcoma , 2016, ACS central science.

[33]  Chengqi Yi,et al.  Transcriptome-wide mapping reveals reversible and dynamic N(1)-methyladenosine methylome. , 2016, Nature chemical biology.

[34]  B. Nawrot,et al.  Nucleoside modifications in the regulation of gene expression: focus on tRNA , 2016, Cellular and Molecular Life Sciences.

[35]  Gideon Rechavi,et al.  The dynamic N1-methyladenosine methylome in eukaryotic messenger RNA , 2016, Nature.

[36]  J. Joung,et al.  High-fidelity CRISPR-Cas9 variants with undetectable genome-wide off-targets , 2015, Nature.

[37]  David A. Scott,et al.  Rationally engineered Cas9 nucleases with improved specificity , 2015, Science.

[38]  C. Bennett,et al.  Synthetic CRISPR RNA-Cas9–guided genome editing in human cells , 2015, Proceedings of the National Academy of Sciences.

[39]  Jennifer A. Doudna,et al.  Conformational control of DNA target cleavage by CRISPR–Cas9 , 2015, Nature.

[40]  Shu-Bing Qian,et al.  Dynamic m6A mRNA methylation directs translational control of heat shock response , 2015, Nature.

[41]  Israel Steinfeld,et al.  Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells , 2015, Nature Biotechnology.

[42]  Howard Y. Chang,et al.  Structure and thermodynamics of N6-methyladenosine in RNA: a spring-loaded base modification. , 2015, Journal of the American Chemical Society.

[43]  J. Szostak,et al.  Crystal Structure Studies of RNA Duplexes Containing s2U:A and s2U:U Base Pairs , 2014, Journal of the American Chemical Society.

[44]  Feng Zhang,et al.  Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA , 2014, Cell.

[45]  R. Micura,et al.  Efficient Access to 3′-Terminal Azide-Modified RNA for Inverse Click-Labeling Patterns , 2013, Bioconjugate chemistry.

[46]  E. Lander,et al.  Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.

[47]  A. Jäschke,et al.  Site-specific one-pot dual labeling of DNA by orthogonal cycloaddition chemistry. , 2012, Bioconjugate chemistry.

[48]  M. Kupiec,et al.  Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq , 2012, Nature.

[49]  R. Weissleder,et al.  Synthesis and evaluation of a series of 1,2,4,5-tetrazines for bioorthogonal conjugation. , 2011, Bioconjugate chemistry.

[50]  C. Bertozzi,et al.  Cu-free click cycloaddition reactions in chemical biology. , 2010, Chemical Society reviews.

[51]  Paul F Agris,et al.  Bringing order to translation: the contributions of transfer RNA anticodon‐domain modifications , 2008, EMBO reports.

[52]  S. Silverman,et al.  Synthesis of amine- and thiol-modified nucleoside phosphoramidites for site-specific introduction of biophysical probes into RNA. , 2005, The Journal of organic chemistry.

[53]  D. Turner,et al.  Thermodynamics of RNA-RNA duplexes with 2- or 4-thiouridines: implications for antisense design and targeting a group I intron. , 1999, Biochemistry.

[54]  R. Kumar,et al.  Synthesis and studies on the effect of 2-thiouridine and 4-thiouridine on sugar conformation and RNA duplex stability. , 1997, Nucleic acids research.